BRPI0912026A2 - formulação homeopática - Google Patents

formulação homeopática

Info

Publication number
BRPI0912026A2
BRPI0912026A2 BRPI0912026A BRPI0912026A BRPI0912026A2 BR PI0912026 A2 BRPI0912026 A2 BR PI0912026A2 BR PI0912026 A BRPI0912026 A BR PI0912026A BR PI0912026 A BRPI0912026 A BR PI0912026A BR PI0912026 A2 BRPI0912026 A2 BR PI0912026A2
Authority
BR
Brazil
Prior art keywords
homeopathic formulation
homeopathic
formulation
Prior art date
Application number
BRPI0912026A
Other languages
English (en)
Inventor
Oswal Gunvant Devichand
Oswal Pooja Gunvant
Original Assignee
Oswal Gunvant Devichand
Oswal Pooja Gunvant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oswal Gunvant Devichand, Oswal Pooja Gunvant filed Critical Oswal Gunvant Devichand
Publication of BRPI0912026A2 publication Critical patent/BRPI0912026A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0912026A 2008-04-29 2009-04-27 formulação homeopática BRPI0912026A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN940MU2008 2008-04-29
PCT/IN2009/000253 WO2009133573A2 (en) 2008-04-29 2009-04-27 A homeopathic formulation

Publications (1)

Publication Number Publication Date
BRPI0912026A2 true BRPI0912026A2 (pt) 2015-10-06

Family

ID=54253313

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912026A BRPI0912026A2 (pt) 2008-04-29 2009-04-27 formulação homeopática

Country Status (15)

Country Link
US (1) US20110038949A1 (pt)
EP (1) EP2296681A4 (pt)
JP (2) JP2011518876A (pt)
KR (1) KR101321031B1 (pt)
CN (1) CN102014939A (pt)
AU (1) AU2009241221B2 (pt)
BR (1) BRPI0912026A2 (pt)
CA (1) CA2722121A1 (pt)
CH (1) CH701268B1 (pt)
EA (1) EA201001592A1 (pt)
IL (1) IL208902A (pt)
MX (1) MX339704B (pt)
MY (1) MY161415A (pt)
SG (1) SG190594A1 (pt)
WO (1) WO2009133573A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110135747A1 (en) * 2008-08-29 2011-06-09 Nancy Josephine Polich Homeopathic therapeutic method
BR112012017073A2 (pt) * 2010-01-11 2015-09-01 Phoenix Biotechnology Inc Método de tratamento de condições neurológicas com glicosídeos cardíacos
WO2011143609A1 (en) * 2010-05-14 2011-11-17 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
MY158522A (en) * 2010-07-21 2016-10-14 Epshtein Oleg Lliich Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory diseases or condition
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
KR102391369B1 (ko) * 2011-03-28 2022-04-26 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 스킨 케어 제형
US9545429B1 (en) * 2011-09-03 2017-01-17 Biolyte Laboratories, Llc Homeopathic formulations
EP2591823A1 (en) * 2011-11-11 2013-05-15 Biologische Heilmittel Heel GmbH Composition for treating or preventing neurodegenerative disorders
RU2484839C1 (ru) * 2012-02-06 2013-06-20 Михаил Михайлович Шашурин Способ получения экстракта рододендрона золотистого с пониженным содержанием стероидных (сердечных) гликозидов
US9278116B2 (en) 2012-03-15 2016-03-08 Princeton Biotechnology Corporation Compositions and methods for treatment of pain
US8551535B1 (en) 2012-08-06 2013-10-08 Sarah McCann Homeopathic remedies and methods for enhancing weight loss
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
WO2015030567A1 (es) * 2013-08-30 2015-03-05 Zamarripa Blas Juan Alberto Mejoras a formulación auxiliar para contrarrestar efectos adversos de tratamientos contra el cáncer y de tratamientos contra algunas enfermedades víricas
KR101540107B1 (ko) * 2015-02-05 2015-07-30 주식회사 다림바이오텍 반복적 희석 및 진탕을 이용한 경구용 제제의 제조방법
US20170290873A1 (en) * 2016-04-08 2017-10-12 Stellalife Method Of Using Homeopathic Kit Containing Gel, Rinse And Spray For Management Of Post-Oral Surgical Recovery And Maintenance Of Oral Health
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10828251B1 (en) 2017-01-14 2020-11-10 Biolyte Laboratories, Llc Homeopathic formulations
US10617634B1 (en) 2017-03-10 2020-04-14 Biolyte Laboratories, Llc Topical homeopathic formulations for menstrual cramps
CA3076963C (en) * 2017-11-30 2022-03-29 Canopy Growth Corporation Liquid dosage forms comprising cannabis, methods of making and use
WO2020072850A1 (en) * 2018-10-04 2020-04-09 Stellalife, Inc. Compositions and methods for promoting and maintaining oral health
EP4069215A4 (en) 2019-12-06 2024-01-17 Jlabs Beauty LLC TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF PREPARING AND USING THE SAME
KR102273322B1 (ko) * 2020-04-29 2021-07-06 우보한의연구소(주) 복합 한약재 추출물을 유효성분으로 포함하는 알츠하이머병 예방, 치료, 또는 개선용 조성물
WO2022011393A1 (en) 2020-07-08 2022-01-13 Shaman Naturals, Llc Compositions for preventing and treating diabetes
RU2746080C1 (ru) * 2020-07-20 2021-04-06 Сергей Анатольевич Небера Гомеопатическое средство для купирования тика век
EP4368172A1 (de) * 2022-11-11 2024-05-15 Gernot A. Overbeck Verfahren zur herstellung eines analogen homöopathischen wirkstoffs, vorrichtung zur durchführung des verfahrens und computerprogrammprodukt
EP4642471A1 (en) * 2022-12-28 2025-11-05 Immune & Genetics Protocols Llc Plant hydroethanolic extracts and uses thereof
EP4642472A1 (en) * 2022-12-28 2025-11-05 O Sigma Cell And Genetic Llc Plant hydroethanolic extracts
WO2025076602A1 (pt) * 2023-10-10 2025-04-17 Ling Huang Wei Composição homeopatica para aumento da energia vital do ser humano e respectiva posologia
GR20230100970A (el) * 2023-11-22 2025-06-13 Παναγουλα Θεοδωρου Μαμμη Αναλγητικο σκευασμα με αμεση θεραπευτικη δραση του πονου που προκαλειται απο αιφνιδια συσπαση των γραμμωτων μυων
KR102845447B1 (ko) 2024-01-26 2025-08-12 주식회사 우신라보타치 아르니카 추출물을 이용한 소염진통 하이드로겔 패치 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2073515C1 (ru) * 1993-01-20 1997-02-20 Игорь Электринович Острейковский Способ лечения травматического поражения головного мозга
RU2074714C1 (ru) * 1993-03-11 1997-03-10 Игорь Электринович Острейковский Способ лечения пациентов с поражением центральной нервной системы
US20060088575A1 (en) * 1994-03-31 2006-04-27 Brewitt Barbara A Homeopathic preparations of purified growth factors and purified growth hormones and associated carriers
DE19738903A1 (de) * 1997-09-05 1999-03-11 Reimar Dr Med Banis Stoffe
RU2143275C1 (ru) * 1999-05-06 1999-12-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения бессонницы и повышенной нервной возбудимости "валериана-плюс мультигран"
RU2150288C1 (ru) 1999-10-25 2000-06-10 Небера Сергей Анатольевич Гомеопатическое средство для лечения спазма аккомодации
RU2224526C1 (ru) * 2002-11-04 2004-02-27 Государственное учреждение Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН Средство для профилактики и лечения боевой психической травмы
GB2414670B (en) * 2003-03-14 2008-03-19 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
US7037532B2 (en) * 2004-03-03 2006-05-02 Innovation Ventures, Llc Hangover relief composition
US20050249763A1 (en) * 2004-04-19 2005-11-10 L'oreal Kit for formulating a cosmetic product
US20060165812A1 (en) * 2005-01-21 2006-07-27 Amershire Investment Corporation Method and topical formulation for treating headaches
US20070275096A1 (en) * 2006-05-19 2007-11-29 Trp, Inc., A Nevada Corporation Composition and methodology for the treatment of hearing impairment symptoms
IES20100493A2 (en) * 2007-10-10 2010-09-15 Thomas Farrington A homeopathic complex

Also Published As

Publication number Publication date
JP5819909B2 (ja) 2015-11-24
MY161415A (en) 2017-04-14
CH701268B1 (de) 2012-06-15
CA2722121A1 (en) 2009-11-05
MX339704B (es) 2016-06-06
US20110038949A1 (en) 2011-02-17
AU2009241221A1 (en) 2009-11-05
KR101321031B1 (ko) 2013-10-23
IL208902A (en) 2015-09-24
JP2011518876A (ja) 2011-06-30
EA201001592A1 (ru) 2011-08-30
CN102014939A (zh) 2011-04-13
JP2014062106A (ja) 2014-04-10
SG190594A1 (en) 2013-06-28
EP2296681A2 (en) 2011-03-23
WO2009133573A2 (en) 2009-11-05
WO2009133573A3 (en) 2010-05-06
EP2296681A4 (en) 2012-04-18
IL208902A0 (en) 2011-01-31
KR20100137013A (ko) 2010-12-29
AU2009241221B2 (en) 2015-02-05
MX2010011715A (es) 2010-12-06

Similar Documents

Publication Publication Date Title
BRPI0912026A2 (pt) formulação homeopática
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0912213A2 (pt) preparação cosmética
DE602008002756D1 (de) Bauzusammensetzung
BRPI0907376A2 (pt) Fotobiorretador
BRPI0920521A2 (pt) combinação farmacêutica
EP2519104A4 (en) PESTICIDE COMPOSITION
BRPI0917231A2 (pt) composição
BRPI0914649A2 (pt) Piprazolo-quinazolinas
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI1009465A2 (pt) Formulação
FR2933868B1 (fr) Compositions cosmetiques
FIC20240018I1 (fi) Vamoroloni
BRPI0914781A2 (pt) Microbiocidas
BRPI0921654A2 (pt) formulação farmacêutica
EP2236149A4 (en) MEDICAL COMPOSITION
EP2350385A4 (en) Forming section
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0907522A2 (pt) biarlamidas
BRPI0921313A2 (pt) composição farmaucêutica
EP2296713A4 (en) DISINFECTANT FORMULATION
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0911199A2 (pt) microbiocidas
BRPI0909634A2 (pt) 2-aminoquinolinas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL